BioPharm International-10-01-2001

BioPharm International

Qualification of Network Components and Validation of Networked Systems

October 15, 2001

14

10

by Ludwig Huber at Agilent Technologies GmbH and Rory Budihandojo To comply with 21 CFR Part 11, your networked systems require the same validation and qualification steps as those for a single computer. Shared servers and multiple access also add requirements that are unique to networks. Italicized words in this article are defined in the "The Glossaryy" on the last page of the online version.

Statistical Tools for Setting In-Process Acceptance Criteria

October 15, 2001

14

10

by Robert J. Seely, Louis Munyakazi, and John Haury Regulatory approval and successful manufacturing depend on establishing meaningful and reasonable acceptance criteria for process validations and ongoing monitoring. Three methods are presented here to correct for the likely underestimation of process limits due to small samples.

Managing Your Career: Recruiter-Proof Your Organization

October 15, 2001

Columns and Departments

14

10

by David G. Jensen Your best people will be targeted.

Employing Murine MAbs as Ancillary Products in Cell Therapy Manufacturing: Part 1, Considerations for Technology Transfer and Commercial Development

October 15, 2001

Product Development

14

10

by Steven Ford and William E. Tente Chimeric Therapies, Inc. Manufacturing processes for murine monoclonal antibodies (mMABs) used in therapeutic applications must address more safety concerns than those used for in vitro diagnostics. Adequate characterization helps ensure that the mMAb retains its functional integrity after more extensive processing.

Inside Washington: Crisis and Costs Grip Biotech Industry

October 15, 2001

Columns and Departments

14

10

by Jill Wechsler Terrorist attack may postpone health policy legislation but encourage antibioterrorism initiatives.

Outsourcing Outlook

October 15, 2001

Columns and Departments

14

10

by Jim Miller